Loading clinical trials...
Loading clinical trials...
This study is a multicenter, single arm phase II clinical study mainly evaluating the efficacy of CM310 in patients with seasonal allergic rhinitis.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Keymed Biosciences Co.Ltd
NCT04815668 · Seasonal Allergic Rhinitis
NCT06846385 · Seasonal Allergic Rhinitis
NCT06837233 · Seasonal Allergic Rhinitis
NCT06046391 · Seasonal Allergic Rhinitis
NCT03570957 · Seasonal Allergic Rhinitis
Beijing Tong-Ren hospital
Beijing
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions